Skip to main content

Table 2 Patients laboratory and clinical findings

From: T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a Cardiovascular Magnetic Resonance study

Laboratory findings, median (IQR)

Value

hs-cTnT, ng/ml

0.029 (0.007–0.057)

CRP, mg/dl

1.4 (0.43–3.93)

D-dimer, ng/dl

750 (580–1824)

WBC × 109/l

5.6 (4.95–8.89)

Lymphocytes × 109/l

1.06 (0.89–1.84)

Clinical findings, mean (SD)

 Respiratory rate, breaths/min

19.5 (2.2)

 O2 sat %

97.2 (1.5)

 PaO2/FiO2 ratio

383.9 (67.5)

 Chest CT Score

9.6 (4.8)

 Time from COVID-19 diagnosis to CMR, median (IQR), days

20.0 (13.5–31.5)

  1. CMR cardiovascular magnetic resonance, CRP c-reactive protein, CT computed tomography, hs-cTnT High-sensitivity troponin T, IQR interquartile range, O2 sat oxygen saturation, PaO2/FiO2 arterial oxygen partial pressure/fraction of inspired oxygen, SD standard deviation, WBC white blood cells